Evid Invest
Who owns MAZEWhat MAZE owns — n/a

Who owns Maze Therapeutics, Inc.?

Prices and market caps: Cboe delayed data, at least 15 minutes delayed. Not real-time. Fundamentals from company filings.

Institutional ownership of MAZE from SEC Form 13F filings across 158 reporting managers. All positions are from one synchronized reporting period — 2026-09-30 books, filed up to 45 days after quarter end — so every row is comparable.

As of the 2026-09-30 reporting period, 158 institutions disclosed 60.4M shares of Maze Therapeutics, Inc. worth $1.64B — about 99.2% of shares outstanding; the largest disclosed holder is Frazier Life Sciences Management, L.P.. Source: SEC Form 13F filings, parsed by EvidInvest.

158

13F holders

$1.64B

value, 2026 filers

99.2%

of shares outstanding (60.4M sh)

22

new positions (2026 filers)

Top institutional holders

ordered by shares owned · positions as of 2026-09-30 · % of fund = share of the manager's own book · % of co. = share of MAZE's shares outstanding

#ManagerSharesValue% of fund% of co.Δ shares QoQ
1Frazier Life Sciences Management, L.P.5.3M$143.6M3.6%8.7%+5.0%
2ARCH Venture Management, LLC4.1M$112.0M6.9%6.8%0.0%
3Deep Track Capital, LP4.1M$111.0M1.8%6.7%+9.4%
4TRV GP IV, LLC3.7M$101.2M67.6%6.1%-16.8%
5BlackRock, Inc.3.7M$100.9M0.0%6.1%+6.0%
6Janus Henderson Group Ltd.NEW3.4M$92.7M0.0%5.6%new
7T. Rowe Price Investment Management, Inc.2.4M$66.0M0.0%4%-6.7%
8VANGUARD CAPITAL MANAGEMENT LLC1.9M$51.1M0.0%3.1%+5.7%
9a16z Capital Management, L.L.C.1.7M$46.3M0.2%2.8%0.0%
10CITADEL ADVISORS LLC1.6M$42.9M0.0%2.6%+85.3%
11Venrock Adviser, LLC1.5M$42.0M2.0%2.5%-3.5%
12Alphabet Inc.1.4M$37.7M0.0%2.3%0.0%
13JPMORGAN CHASE & CO1.2M$32.9M0.0%2%+26.0%
14MARSHALL WACE, LLP1.2M$31.7M0.0%1.9%+27.5%
15BRAIDWELL LP1.1M$31.2M1.3%1.9%+0.9%
16FMR LLC1.1M$30.8M0.0%1.9%+7.2%
17STATE STREET CORP1.1M$30.5M0.0%1.8%+12.5%
18FARALLON CAPITAL MANAGEMENT, L.L.C.1.1M$30.1M0.1%1.8%0.0%
19General Catalyst Group Management, LLC1.0M$28.2M5.9%1.7%0.0%
20GEODE CAPITAL MANAGEMENT, LLC955,071$26.0M0.0%1.6%+11.3%
21TRV GP V, LLC950,800$25.8M5.4%1.6%0.0%
22Driehaus Capital Management LLC947,544$25.8M0.2%1.6%-0.8%
23Logos Global Management LP935,000$25.4M1.4%1.5%-51.7%
24GOLDMAN SACHS GROUP INC846,632$23.0M0.0%1.4%+188.8%
25Casdin Capital, LLC843,857$22.9M1.0%1.4%0.0%

Source: SEC Form 13F-HR filings (institutional managers over $100M in US-listed positions). 13Fs disclose long positions only, up to 45 days after quarter end; each manager's latest filed quarter is shown per row and dollar values are the manager's filed marks. Aggregates labeled "2026 filers" count only managers whose latest book is a 2026 quarter. Related: valuation · options positioning · supply chain. Research, not investment advice.

EvidInvest is an independent research and information tool. Figures are calculated from public SEC filings and third-party market data and are provided for informational and educational purposes only. EvidInvest does not provide investment advice, brokerage, or financial services, and is not affiliated with any company it covers. Verify all figures against primary sources before making any decision.